Yi Shi

Adjuvant atezolizumab versus observation in muscle-invasive urothelial carcinoma (IMvigor010): a multicentre, open-label, randomised, phase 3 trial

Joaquim Bellmunt, Maha Hussain, Jürgen E. Gschwend et al. · The Lancet Oncology · 2021 · 393 citations · Full text

Urology, Versus Observation, Genitourinary Cancer +6

Chinese red yeast rice (Monascus purpureus) for primary hyperlipidemia: a meta-analysis of randomized controlled trials.

Jianping Liu, Jing Zhang, Yi Shi et al. · Chinese Medicine · 2006 · 234 citations · Full text

Nutrition, Nutraceutical Ingredient, Hyperlipidemia +16

Diagnostic Value of Galactomannan Antigen Test in Serum and Bronchoalveolar Lavage Fluid Samples from Patients with Nonneutropenic Invasive Pulmonary Aspergillosis

Wei Zhou, Hongxing Li, Yan Zhang et al. · Journal of Clinical Microbiology · 2017 · 193 citations · Full text

Aetiology of severe community acquired pneumonia in adults identified by combined detection methods: a multi-centre prospective study in China

Jieming Qu, Jing Zhang, Yu Chen et al. · Emerging Microbes & Infections · 2022 · 125 citations · Full text

Diagnosis, Multi-centre Prospective Study, Healthcare-associated Infection +16

Updated Overall Survival by Circulating Tumor DNA Status from the Phase 3 IMvigor010 Trial: Adjuvant Atezolizumab Versus Observation in Muscle-invasive Urothelial Carcinoma

Thomas Powles, Zoe J. Assaf, Viraj Degaonkar et al. · European Urology · 2023 · 112 citations

Urology, Overall Survival, Genitourinary Cancer +6